Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDiagnostic Performance and Quantitative Analysis of [18F]FET PET in Brain Tumours
Description:
This is a retrospective study encompassing all \[18F\]FET PET scans performed at our centre. By analysing both static and dynamic scans, conducting in-depth kinetic modelling, and comparing quantitative parameters across different tumour types and clinical contexts, the study aims to determine the true diagnostic value of \[18F\]FET PET in everyday clinical practice. The ultimate goal is to identify imaging biomarkers useful for improving tumour characterisation and distinguishing recurrence from post-treatment changes, thereby strengthening the role of \[18F\]FET PET in modern neuro-oncology.
Sponsor:
IRCCS San Raffaele
Contacts:
Chiara Catalano, PhD (CONTACT)catalano.chiara@hsr.it
+39 0226433639
Alexandra Lazar, Dr. (CONTACT)lazar.alexandra@hsr.it
Government Study Link:
NCT07599917 - Click here to see study onClinicalTrials.gov
FET
- Amino Acid Transport
- Patients who underwent a brain PET/CT or PET/MRI scan with \[18F\]FET for clinical reasons during the study period.
- Availability of the corresponding static and dynamic images.
- . Pregnancy or breastfeeding
Share your feedback
Help us improve your experience